Click here to close
New Message Alert
How Well the Vaccine Works- Pfizer-BioNTech (COMIRNATY) vaccine was 95% eff


How Well the Vaccine Works- Pfizer-BioNTech (COMIRNATY) vaccine was 95% eff  

  Click Here to have an E-mail Sent to you when a new message is added to this thread
Author: TheCrow   Date: 10/1/2021 10:46:57 AM  +2/-1   Show Orig. Msg (this window) Or  In New Window

I would rather be one of the 19 of 20 who are not clinically infected with covid than the 1 in 20 who is. Of course, the odds of surviving the infection are pretty good, it only kills 1.6% of the infected. 


If you're vaccinated, the mortality rate of 'breakthrough infections' is 0.0008% of those infected. Got that? You're 2000 times more likely to die of a covid infection if you aren't vaccinated.


If tetanus, polio, smallpox vaccinations are reasonable, then covid vaccination is infinitely more reasonable. tetanus exposure is probably pretty common but an average of only 10 Americans are killed annually; Polio has been eradicated and smallpox nealy so, the last case was seen in 1976 Bangladesh- vaccinations!


On the other hand, covid 19 is killing hundreds of thousands of Americans and infecting millions:


United States Coronavirus Cases: 44,315,162
Deaths: 716,849


It is estimated that 787,834 Americans will die of COVID-19 this year. The epidemic will continue into 2022.


 


How Well the Vaccine Works



  • Based on evidence from clinical trials in people 16 years and older, the Pfizer-BioNTech (COMIRNATY) vaccine was 95% effective at preventing laboratory-confirmed infection with the virus that causes COVID-19 in people who received two doses and had no evidence of being previously infected.

  • In clinical trials, the Pfizer-BioNTech vaccine was also highly effective at preventing laboratory-confirmed COVID-19 infection in adolescents 12–15 years old, and the immune response in people 12–15 years old was at least as strong as the immune response in people 16–25 years old.

  • The vaccine was also highly effective in clinical trials at preventing COVID-19 among people of diverse age, sex, race, and ethnicity categories and among people with underlying medical conditions.

  • Evidence shows mRNA COVID-19 vaccines offer similar protection in real-world conditions as they have in clinical trial settings―reducing the risk of COVID-19, including severe illness by 90% or more, among people who are fully vaccinated.

  • CDC will continue to provide updates as we learn more.


 
    Return-To-Index   Display Full Msg Thread  FLAG This Message